文献速递帕金森病与运动障碍

帕金森病患者焦虑检测工具的系统综述

Detecting anxiety in individuals with Parkinson disease: A systematic review.
PubMed 文献 · Neurology · 2017-12-06

该系统综述旨在评估门诊成人帕金森病患者中焦虑检测工具与金标准相比的诊断准确性。检索MEDLINE、EMABASE、PsycINFO和Cochrane系统综述数据库至2017年4月7日,共纳入6篇全文。焦虑的合并患病率为30.1%(95%CI 26.1%-34.0%)。GAI的灵敏度为0.86、特异度为0.88;PAS的灵敏度为0.71、特异度最高为0.91。

要点

  • 帕金森病患者焦虑合并患病率为30.1%(95%CI 26.1%-34.0%)。
  • GAI简短易用,灵敏度0.86、特异度0.88,平衡性较好。
  • PAS为PD专门开发,特异度最高0.91,但灵敏度较低为0.71。

核心结论

  • 有6种工具在帕金森病人群中验证用于焦虑筛查,但多数工具仅在单一研究中验证。
  • GAI简短易用且灵敏度与特异度平衡较好;PAS为PD专门开发、简短且有自评/他评版本,但灵敏度较低。

研究设计与样本

  • 系统综述,检索MEDLINE、EMABASE、PsycINFO和Cochrane系统综述数据库至2017年4月7日。
  • 共审阅6,300条引文,纳入6篇全文进行合成。

主要发现

  • 焦虑合并患病率为30.1%(95%CI 26.1%-34.0%)。
  • GAI报告的灵敏度为0.86、特异度为0.88。
  • 观察者评定的PAS灵敏度为0.71,特异度最高为0.91。

关键数值与推荐

  • 纳入工具包括Beck焦虑量表、老年焦虑量表(GAI)、汉密尔顿焦虑量表、医院焦虑抑郁量表-焦虑亚量表、帕金森焦虑量表(PAS)和迷你社交恐惧量表。
  • 焦虑诊断包括广泛性焦虑障碍、社交恐惧症和任何焦虑类型。

临床怎么用

  • 从事帕金森病照护的医疗从业者应了解可用的验证工具,并选择适合其实践的工具。

局限性

  • 多数工具仅在单一研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine diagnostic accuracy of anxiety detection tools compared with a gold standard in outpatient settings among adults with Parkinson disease (PD). METHODS: A systematic review was conducted. MEDLINE, EMABASE, PsycINFO, and Cochrane Database of Systematic Reviews were searched to April 7, 2017. Prevalence of anxiety and diagnostic accuracy measures including sensitivity, specificity, and likelihood ratios were gathered. Pooled prevalence of anxiety was calculated using Mantel-Haenszel-weighted DerSimonian and Laird models. RESULTS: A total of 6,300 citations were reviewed with 6 full-text articles included for synthesis. Tools included within this study were the Beck Anxiety Inventory, Geriatric Anxiety Inventory (GAI), Hamilton Anxiety Rating Scale, Hospital Anxiety and Depression Scale-Anxiety, Parkinson's Anxiety Scale (PAS), and Mini-Social Phobia Inventory. Anxiety diagnoses made included generalized anxiety disorder, social phobia, and any anxiety type. Pooled prevalence of anxiety was 30.1% (95% confidence interval 26.1%-34.0%). The GAI had the best-reported sensitivity of 0.86 and specificity of 0.88. The observer-rated PAS had a sensitivity of 0.71 and the highest specificity of 0.91. CONCLUSIONS: While there are 6 tools validated for anxiety screening in PD populations, most tools are only validated in single studies. The GAI is brief and easy to use, with a good balance of sensitivity and specificity. The PAS was specifically developed for PD, is brief, and has self-/observer-rated scales, but with lower sensitivity. Health care practitioners involved in PD care need to be aware of available validated tools and choose one that fits their practice.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mele B, Holroyd-Leduc J, Smith EE, et al. Detecting anxiety in individuals with Parkinson disease: A systematic review. Neurology. 2017. PMID: 29212828. doi:10.1212/WNL.0000000000004771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。